Information
Diabecon is a phytopharmaceutical formulation for the effective management of type II diabetes.
The natural ingredients in Diabecon increase insulin secretion in the body. By reducing the glycated hemoglobin level (form of hemoglobin used to measure glucose content in the blood), normalizing microalbuminuria (a condition which is an important prognostic marker for kidney disease in diabetes mellitus) and modulating the lipid profile.
Diabecon reduces high glucose content in the blood. Effective hyperglycemic control is important in preventing micro- and macrovascular complications (large and small blood vessels) complications arising from diabetes. Gymnema’s (Meshashringi) principal constituent is gymnemic acid, which has antidiabetic properties. It reduces excessive blood sugar. It also has a regenerative effect on pancreatic beta cells and it stimulates the production and activity of insulin.
Indian Kino Tree’s (Pitasara) principal constituent, epicatechin, has alpha-glucosidase inhibitory properties and regularizes key metabolic enzymes involved in carbohydrate metabolism.
Shilajeet decreases hepatic glucose production and prevents hyperglycemia. Shilajeet has a protective action on b-cells of the pancreas, and promotes unrestricted endogenous insulin action.
The natural ingredients in Diabecon increase insulin secretion in the body. By reducing the glycated hemoglobin level (form of hemoglobin used to measure glucose content in the blood), normalizing microalbuminuria (a condition which is an important prognostic marker for kidney disease in diabetes mellitus) and modulating the lipid profile.
Diabecon reduces high glucose content in the blood. Effective hyperglycemic control is important in preventing micro- and macrovascular complications (large and small blood vessels) complications arising from diabetes.
Role of Key ingredients:
Indian Kino Tree’s (Pitasara) principal constituent, epicatechin, has alpha-glucosidase inhibitory properties and regularizes key metabolic enzymes involved in carbohydrate metabolism.
Shilajeet decreases hepatic glucose production and prevents hyperglycemia. Shilajeet has a protective action on b-cells of the pancreas, and promotes unrestricted endogenous insulin action.
Use under medical supervision
Reviews
There are no reviews yet.